Connect with us

Business

Marijuana MSO Parallel faces financial hurdles after $1.9B SPAC deal collapses

Published

on

In February 2021, chewing gum heir William “Beau” Wrigley Jr. and his Parallel marijuana company seemed on the verge of completing a $1.9 billion deal to go public through a special purpose acquisition company (SPAC) backed by music mogul Scooter Braun.

The blockbuster transaction – combining multistate operator Parallel and Braun’s Ceres Acquisition Corp. – was promoted in Parallel’s presentation to investors as bringing together two “industry titans.”

But the merger collapsed without explanation last September, and, soon after, Wrigley stepped down as CEO.

Now, Wrigley, Atlanta-based Parallel and some of its top executives face litigation – including a lawsuit in U.S. District Court in southern Florida by investors alleging securities fraud, mismanagement and misrepresentation.

Among other things, the three disgruntled investment groups accuse Wrigley of deliberately letting the SPAC deal “die on the vine” when it was clear the merged company would fail to live up to expectations.

They also accuse Wrigley of spending their investment on servicing debt rather than on company operations.

The plaintiffs are seeking a minimum of $25 million in damages plus expenses.

But in a recent motion to dismiss, Parallel and other defendants reject the allegations, saying the case doesn’t involve fraud but rather “disappointed investors.”

The collapse of the Ceres-Parallel deal and the ensuing fallout underscore the overly ambitious expansion plans of some cannabis companies as well as the boom and bust of SPACs.

In Parallel’s case, court filings, investor presentations and other disclosures reflect a company that trumpeted lofty ambitions but struggled under the weight of massive debt and unrealized growth projections.

For example:

  • In August 2021, Parallel – which also does business in some states as Surterra Wellness – projected its 2022 revenue would be $618 million. But by January of this year, the company had slashed that projection by 40%, to $362 million.
  • Parallel struggled to have enough cash to avoid defaulting on $350 million in debt.
  • Even before the SPAC deal was announced, Parallel had posted net losses of $263 million in 2019 and $140 million in 2020.

After the Scooter Braun deal unraveled, court filings indicate that Parallel told the investors it was pursuing a sale of the company that would be completed by mid-2022. That also hasn’t materialized.

Parallel declined to comment to MJBizDaily about the litigation, its current financial condition and whether the company is for sale.

Despite its financial challenges, industry experts see Parallel as being a potentially desirable acquisition target.

When the SPAC transaction was announced in February 2021, Parallel had long held the No. 2 sales position in Florida’s mammoth medical marijuana market, behind Florida-based MSO Trulieve Cannabis.

The company also boasted operations or licenses in Massachusetts, Nevada, Pennsylvania and Texas.

“Parallel has an attractive footprint which includes the highly coveted Florida market,” Matt Karnes, founder of New York-based Green Wave Advisors, told MJBizDaily via email.

But its struggle to service its debts “raises concern around its liquidity and, perhaps, even its ability to continue as an ongoing concern,” Karnes added.

It’s difficult to know exactly the current status of Parallel’s financial health and its debt payments because the company is privately held.

Lofty projections

Circle back to February 2021, when Wrigley struck the mammoth deal with Braun to take Parallel public through a transaction that valued the company at nearly $2 billion.

Under the terms of the transaction, Braun’s Ceres would buy Wrigley’s Parallel and then Parallel would take Ceres’ stock listing on Canada’s NEO Exchange.

The combined public company was expected to have a $430 million cash balance at closing that included $120 million held by Ceres, according to a news release announcing the deal.

Parallel at the time forecasted $447 million in 2021 revenue. That included $102 million in earnings before interest, taxes, depreciation and amortization (EBITDA).

EBITDA is considered an alternative measurement of a company’s overall financial performance versus the more widely used net income.

According to an investor presentation in October 2021, Parallel had a total of 42 stores – 39 in Florida, two in Massachusetts and one in Nevada – as well as licenses in Pennsylvania and Texas.

The SPAC deal was expected to close by the summer. But it was scrapped in September 2021 without explanation.

For one thing, the SPAC market had cooled as regulations tightened and the economic climate softened with interest rates rising.

But Reuters – citing anonymous sources – reported that “several investors had lost confidence in Parallel’s ability to deliver on lofty financial projections it provided in February when the merger was announced.”

Along with those aggressive financial projections, Parallel said at the time that it planned to more than double its retail outlets, from 42 to 86, within two years, according to a February 2021 investor presentation.

In addition to adding retail stores in existing markets, Parallel expressed confidence in winning licenses in Georgia, New Jersey and Virginia.

In Florida alone, Parallel said it would add 18 stores by 2022, bringing its total to 57.

But the company so far has added only six.

As other MSOs have aggressively expanded in Florida, Parallel has slipped from second to fifth in market share in THC milligram and flower sales, according to recent state data.

The company is still second in CBD product sales.

Pivot to private sale

As the Braun-backed SPAC deal collapsed, court filings indicate that Parallel pivoted, saying it would pursue a private sale of the company.

Three investment groups, led by Bahamas-based TradeInvest Asset Management, allege in the securities fraud lawsuit in Florida federal court that they were “fraudulently” induced to invest $25 million to support Parallel’s operating expenses until the SPAC could be completed.

But by August 2021, the plaintiffs claim, the value of the SPAC transaction had been slashed to just more than $1 billion from $1.9 billion when the deal was announced in February of that year.

Wrigley, the plaintiffs claim, “understood the company’s poor performance would translate to poor performance in the public markets. He therefore let the SPAC transaction die on the vine.”

Parallel then sold the $25 million investment “as a way to ‘bridge’ the company’s operating and capital expenditures” until an alternative sale was completed in the first half of 2022, the TradeInvest lawsuit claims.

“In reality, however, the (investment) was a bridge to nowhere. … Wrigley and his co-defendants were secretly just trying to keep the company from collapsing under the weight of its debt,” the lawsuit claims.

Instead, the plaintiffs allege, their money was used by Parallel to avoid debt defaults rather than on company operations.

The suit claims that $3 million was used to partly pay Wrigley for a $13.5 million note that Wrigley’s “family office” had issued to the company at terms “that would make a loan shark jealous.”

The so-called PE Fund note carried a $2.5 million transaction fee and 16% annual interest rate, according to the plaintiffs, who claim Wrigley improperly had an interest in both sides of the transaction.

The plaintiffs allege the same conflict of interest with another Wrigley family loan to the company.

In addition to asking for at least $25 million in damages, the plaintiffs want the court to invalidate, or declare unacceptable, the Wrigley “investment vehicles.”

In a June motion to dismiss the securities-fraud lawsuit, Parallel acknowledges its financial challenges while denying allegations of fraud and self-dealing.

“This is not a case of fraud, but of disappointed investors,” the defendants, which include Wrigley individually, say in the court filing.

“Plaintiffs are sophisticated investors in Parallel, a privately-held cannabis company. In their sweeping 164-paragraph complaint, plaintiffs take issue with the management of the business and assert various scandalous (and fictional) allegations of mismanagement and self-dealing.

“Although plaintiffs take great liberties with the facts, it is no secret that the company has suffered a series of financial setbacks recently, making it difficult for it to maintain its operations and service its debts.”

The court response by the defendants added that the “allegations, at best, represent nothing more than plaintiffs’ dissatisfaction over how the company used the money that Wrigley invested.”

The $3 million, the response indicates, was used to make a contractually required debt payment and that disclosures to the investors expressly stated that management had “broad discretion” in deciding how to use the investment.

Illinois deal

A key part of Parallel’s growth plan involved a $100 million acquisition announced in April 2021 to buy six Windy City Cannabis shops in the fast-growing Illinois recreational marijuana market.

But that deal also collapsed, and Windy City owner Steve Weisman is seeking $80 million in damages as well as potential earnouts from Wrigley and Parallel.

Performance-based earnouts would have pushed the potential total price tag to $155 million.

Weisman, according to court documents, argues that Wrigley should be personally liable for damages because Parallel essentially is Wrigley’s “alter ego.”

Parallel declined comment about the Windy City deal.

Wrigley recently filed a lawsuit in U.S. District Court in Chicago seeking to be excluded from an arbitration on the matter,  maintaining that he wasn’t a party or signatory to the agreement to purchase the Windy City stores.

And what about the new markets that Parallel planned to enter, Georgia, New Jersey and Virginia?

So far, none of those moves have come to fruition, although Surterra Wellness says on its website that it has an “active application” in New Jersey.

Karnes of GreenWave Advisors said any potential suitor will have to keep in mind concerns about Parallel’s debt and liquidity.

“That said, Parallel may be considered an attractive acquisition candidate at a distressed valuation though a vigorous due diligence process is particularly necessary given this heightened level of uncertainty and ‘red flags.’”

Source: https://mjbizdaily.com/marijuana-mso-parallel-faces-financial-hurdles-after-1-9-billion-spac-deal-collapses/

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

AI & Technology

Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations

Published

on

By

Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).

The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.

Trial Push Despite Multi-Million Euro Settlement

The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.

Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.

A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.

Allegations of VAT Evasion Through Marketplace Sellers

At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.

Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.

Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.

Italian Government Named as Affected Party

In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.

Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.

Multiple Investigations Add to Pressure

The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.

Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.

In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.

Amazon Denies Allegations

Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.

Broader Impact on Europe’s Digital Economy

If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.

With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News